142 related articles for article (PubMed ID: 17312045)
21. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.
Even-Sapir E
J Nucl Med; 2005 Aug; 46(8):1356-67. PubMed ID: 16085595
[TBL] [Abstract][Full Text] [Related]
22. Limitations of CT during PET/CT.
Gollub MJ; Hong R; Sarasohn DM; Akhurst T
J Nucl Med; 2007 Oct; 48(10):1583-91. PubMed ID: 17873133
[TBL] [Abstract][Full Text] [Related]
23. Automated 3-dimensional elastic registration of whole-body PET and CT from separate or combined scanners.
Shekhar R; Walimbe V; Raja S; Zagrodsky V; Kanvinde M; Wu G; Bybel B
J Nucl Med; 2005 Sep; 46(9):1488-96. PubMed ID: 16157532
[TBL] [Abstract][Full Text] [Related]
24. Added value of PET and PET-computed tomography in oesophageal cancer: a review of current practice.
Douis H; Jafri M
Nucl Med Commun; 2008 Sep; 29(9):840. PubMed ID: 18677217
[No Abstract] [Full Text] [Related]
25. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K
Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840
[TBL] [Abstract][Full Text] [Related]
26. Screening for cancer with PET and PET/CT: potential and limitations.
Schöder H; Gönen M
J Nucl Med; 2007 Jan; 48 Suppl 1():4S-18S. PubMed ID: 17204716
[TBL] [Abstract][Full Text] [Related]
27. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
[TBL] [Abstract][Full Text] [Related]
28. Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.
Nakamoto Y; Sakamoto S; Okada T; Senda M; Higashi T; Saga T; Togashi K
AJR Am J Roentgenol; 2007 Jan; 188(1):257-67. PubMed ID: 17179375
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
30. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
[TBL] [Abstract][Full Text] [Related]
31. PET/CT and radiotherapy.
Messa C; Di Muzio N; Picchio M; Gilardi MC; Bettinardi V; Fazio F
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):4-14. PubMed ID: 16557199
[TBL] [Abstract][Full Text] [Related]
32. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
[TBL] [Abstract][Full Text] [Related]
33. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen.
Kuehl H; Veit P; Rosenbaum SJ; Bockisch A; Antoch G
J Nucl Med; 2007 Jan; 48 Suppl 1():45S-57S. PubMed ID: 17204720
[TBL] [Abstract][Full Text] [Related]
34. Integrated PET/CT for cardiac imaging.
Di Carli MF; Dorbala S
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):44-52. PubMed ID: 16557203
[TBL] [Abstract][Full Text] [Related]
35. Towards truly integrated hardware fusion with PET/CT.
Beyer T
Nuklearmedizin; 2005; 44 Suppl 1():S5-12. PubMed ID: 16395972
[TBL] [Abstract][Full Text] [Related]
36. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
[TBL] [Abstract][Full Text] [Related]
37. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
Hallett WA; Maguire RP; McCarthy TJ; Schmidt ME; Young H
IDrugs; 2007 Nov; 10(11):791-6. PubMed ID: 17968761
[TBL] [Abstract][Full Text] [Related]
38. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
[TBL] [Abstract][Full Text] [Related]
39. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
Nagarajah J; Dannat T; Hartung V; Bockisch A; Rosenbaum-Krumme S
Nuklearmedizin; 2012; 51(3):84-7. PubMed ID: 22366817
[TBL] [Abstract][Full Text] [Related]
40. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.
Kinahan PE; Hasegawa BH; Beyer T
Semin Nucl Med; 2003 Jul; 33(3):166-79. PubMed ID: 12931319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
